Literature DB >> 11286896

Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye.

J Flammer1, M Pache, T Resink.   

Abstract

Vasospasm can have many different causes and can occur in a variety of diseases, including infectious, autoimmune, and ophthalmic diseases, as well as in otherwise healthy subjects. We distinguish between the primary vasospastic syndrome and secondary vasospasm. The term "vasospastic syndrome" summarizes the symptoms of patients having such a diathesis as responding with spasm to stimuli like cold or emotional stress. Secondary vasospasm can occur in a number of autoimmune diseases, such as multiple sclerosis, lupus erythematosus, antiphospholipid syndrome, rheumatoid polyarthritis, giant cell arteritis, Behcet's disease, Buerger's disease and preeclampsia, and also in infectious diseases such as AIDS. Other potential causes for vasospasm are hemorrhages, homocysteinemia, head injury, acute intermittent porphyria, sickle cell disease, anorexia nervosa, Susac syndrome, mitochondriopathies, tumors, colitis ulcerosa, Crohn's disease, arteriosclerosis and drugs. Patients with primary vasospastic syndrome tend to suffer from cold hands, low blood pressure, and even migraine and silent myocardial ischemia. Valuable diagnostic tools for vasospastic diathesis are nailfold capillary microscopy and angiography, but probably the best indicator is an increased plasma level of endothelin-1. The eye is frequently involved in the vasospastic syndrome, and ocular manifestations of vasospasm include alteration of conjunctival vessels, corneal edema, retinal arterial and venous occlusions, choroidal ischemia, amaurosis fugax, AION, and glaucoma. Since the clinical impact of vascular dysregulation has only really been appreciated in the last few years, there has been little research in the according therapeutic field. The role of calcium channel blockers, magnesium, endothelin and glutamate antagonists, and gene therapy are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11286896     DOI: 10.1016/s1350-9462(00)00028-8

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  92 in total

1.  Spatial pattern of glaucomatous visual field loss obtained with regionally condensed stimulus arrangements.

Authors:  Ulrich Schiefer; Eleni Papageorgiou; Pamela A Sample; John P Pascual; Bettina Selig; Elke Krapp; Jens Paetzold
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

2.  [Color Doppler sonography of retrobulbar vessels and hypercapnia in normal tension glaucoma].

Authors:  N Plange; M Bienert; A Harris; A Remky; K O Arend
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

3.  Evidence-based pathophysiology of glaucoma.

Authors:  Cristina Alexandrescu; Ana-Maria Dascalu; Costin Mitulescu; Aida Panca; Ruxandra Pascu; Radu Ciuluvica; V Potop; Liliana Mary Voinea
Journal:  Maedica (Buchar)       Date:  2010-07

4.  Retinal vascular diameter in young subjects with a vasospastic propensity.

Authors:  Fabrizio Branca; Selim Orgül; Claudia Zawinka; Graziella Reinhard; Josef Flammer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

5.  Blood flow in glaucoma.

Authors:  S Orgül
Journal:  Br J Ophthalmol       Date:  2007-01       Impact factor: 4.638

6.  Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma.

Authors:  A Luksch; G Rainer; D Koyuncu; P Ehrlich; T Maca; M E Gschwandtner; C Vass; L Schmetterer
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

7.  Influence of oxygen free radicals on the tone of ciliary arteries: a model of vasospasms of ocular vasculature.

Authors:  Oliver Zeitz; Lars Wagenfeld; Nick Wirtz; Peter Galambos; Natalya Matthiesen; Anne Wiermann; Gisbert Richard; Maren Klemm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-25       Impact factor: 3.117

Review 8.  Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature.

Authors:  Sarthak Gupta; Robert Zivadinov; Deepa Ramasamy; Julian L Ambrus
Journal:  Clin Rheumatol       Date:  2013-11-26       Impact factor: 2.980

Review 9.  Ophthalmologic migraine.

Authors:  Robert F Saul
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 10.  Perceptive aspects of visual aura.

Authors:  Carlo Aleci; William Liboni
Journal:  Neurol Sci       Date:  2009-09-25       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.